These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3648 related articles for article (PubMed ID: 6732071)

  • 1. Computerized histopathologic assessment of malignant potential. III. Refinements of measurement and data analysis.
    Gamel JW; McLean IW
    Anal Quant Cytol; 1984 Mar; 6(1):37-44. PubMed ID: 6732071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections.
    Moshari A; McLean IW
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1160-3. PubMed ID: 11328722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveal melanoma: the importance of large nucleoli in predicting patient outcome--an automated image analysis study.
    McLean IW; Sibug ME; Becker RL; McCurdy JB
    Cancer; 1997 Mar; 79(5):982-8. PubMed ID: 9041161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computerized histopathologic assessment of malignant potential. II. A practical method for predicting survival following enucleation for uveal melanoma.
    Gamel JW; McLean IW
    Cancer; 1983 Sep; 52(6):1032-8. PubMed ID: 6883272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective assessment of the malignant potential of intraocular melanomas with standard microslides stained with hematoxylin-eosin.
    Gamel JW; McLean I; Greenberg RA; Naids RM; Folberg R; Donoso LA; Seddon JM; Albert DM
    Hum Pathol; 1985 Jul; 16(7):689-92. PubMed ID: 2408986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple, efficient, and reproducible method for estimating the malignant potential of uveal melanoma from routine H & E slides.
    McCurdy J; Gamel J; McLean I
    Pathol Res Pract; 1991 Dec; 187(8):1025-7. PubMed ID: 1792184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma.
    Seregard S; Spångberg B; Juul C; Oskarsson M
    Ophthalmology; 1998 Mar; 105(3):485-91. PubMed ID: 9499780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of metastasis of uveal melanoma: comparison of morphometric determination of nucleolar size and spectrophotometric determination of DNA.
    McLean IW; Gamel JW
    Invest Ophthalmol Vis Sci; 1988 Apr; 29(4):507-11. PubMed ID: 3356509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized histologic assessment of malignant potential: a method for determining the prognosis of uveal melanomas.
    Gamel JW; McLean IW; Greenberg RA; Zimmerman LE; Lichtenstein SJ
    Hum Pathol; 1982 Oct; 13(10):893-7. PubMed ID: 7129406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple cytologic method for predicting the malignant potential of intraocular melanoma.
    Huntington A; Haugan P; Gamel J; McLean I
    Pathol Res Pract; 1989 Nov; 185(5):631-4. PubMed ID: 2696944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern developments in histopathologic assessment of uveal melanomas.
    Gamel JW; McLean IW
    Ophthalmology; 1984 Jun; 91(6):679-84. PubMed ID: 6462626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry of uveal melanomas.
    Shapiro BE; Felberg NT; Donoso LA; Augsburger JJ; Shields JA; Gamel J
    Cancer Biochem Biophys; 1986 Jul; 8(3):235-8. PubMed ID: 3742483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of clinical estimates of tumor dimensions. A clinical-pathologic correlation study of posterior uveal melanomas.
    Augsburger JJ; Gamel JW; Bailey RS; Donoso LA; Gonder JR; Shields JA
    Retina; 1985; 5(1):26-9. PubMed ID: 4001586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of direct and microslide pathology measurements of uveal melanomas.
    Folberg R; Gamel JW; Greenberg RA; Donoso LA; Naids RM
    Invest Ophthalmol Vis Sci; 1985 Dec; 26(12):1788-91. PubMed ID: 4066217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Nucleoli Cytomorphology Assessment in Patients With Uveal Melanoma.
    Berus T; Markiewicz A; Biecek P; Orłowska-Heitzman J; Hałoń A; Romanowska-Dixon B; Donizy P
    Anticancer Res; 2020 Jun; 40(6):3505-3512. PubMed ID: 32487651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomorphometry of uveal melanoma. Comparison of fine needle aspiration biopsy samples with histologic sections.
    Char DH; Kroll SM; Stoloff A; Kaleta-Michaels S; Crawford JB; Miller TR; Howes EL; Ljung BM
    Anal Quant Cytol Histol; 1991 Aug; 13(4):293-9. PubMed ID: 1718300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
    Al-Jamal RT; Kivelä T
    Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AgNOR values in Callender histopathological types of malignant uveal melanomas.
    Mera M
    Rom J Morphol Embryol; 1995; 41(3-4):125-8. PubMed ID: 8772368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of melanoma cell type in uveal melanoma following treatment failure.
    Char DH; Miller T; Crawford JB
    Am J Ophthalmol; 2004 Oct; 138(4):543-6. PubMed ID: 15488778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 183.